ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)

M. Mikulska; S. Lanini; C. Gudiol; L. Drgona; G. Ippolito; M. Fernández-Ruiz; B. Salzberger

doi:10.1016/j.cmi.2018.02.003

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)

M. Mikulska, S. Lanini, C. Gudiol, L. Drgona, G. Ippolito, M. Fernández-Ruiz, B. Salzberger

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Clinical Microbiology and Infection
DOIs	https://doi.org/10.1016/j.cmi.2018.02.003
Publication status	Published - 2018

Access to Document

10.1016/j.cmi.2018.02.003

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042918883&doi=10.1016%2fj.cmi.2018.02.003&partnerID=40&md5=10eea75b71acebb822bd3d03fb90955a

Cite this

Mikulska, M., Lanini, S., Gudiol, C., Drgona, L., Ippolito, G., Fernández-Ruiz, M., & Salzberger, B. (2018). ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52). Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2018.02.003

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52). / Mikulska, M.; Lanini, S.; Gudiol, C.; Drgona, L.; Ippolito, G.; Fernández-Ruiz, M.; Salzberger, B.

In: Clinical Microbiology and Infection, 2018.

Research output: Contribution to journal › Article › peer-review

Mikulska, M , Lanini, S, Gudiol, C, Drgona, L, Ippolito, G, Fernández-Ruiz, M & Salzberger, B 2018, 'ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)', Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2018.02.003

Mikulska M , Lanini S, Gudiol C, Drgona L, Ippolito G, Fernández-Ruiz M et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52). Clinical Microbiology and Infection. 2018. https://doi.org/10.1016/j.cmi.2018.02.003

Mikulska, M. ; Lanini, S. ; Gudiol, C. ; Drgona, L. ; Ippolito, G. ; Fernández-Ruiz, M. ; Salzberger, B. / ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52). In: Clinical Microbiology and Infection. 2018.

@article{40a7e004b0eb4a018298ebd2eb4f29c9,

title = "ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)",

author = "M. Mikulska and S. Lanini and C. Gudiol and L. Drgona and G. Ippolito and M. Fern{\'a}ndez-Ruiz and B. Salzberger",

note = "Export Date: 13 April 2018 Article in Press",

year = "2018",

doi = "10.1016/j.cmi.2018.02.003",

language = "English",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)

AU - Mikulska, M.

AU - Lanini, S.

AU - Gudiol, C.

AU - Drgona, L.

AU - Ippolito, G.

AU - Fernández-Ruiz, M.

AU - Salzberger, B.

N1 - Export Date: 13 April 2018 Article in Press

PY - 2018

Y1 - 2018

U2 - 10.1016/j.cmi.2018.02.003

DO - 10.1016/j.cmi.2018.02.003

M3 - Article

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

ER -